Protech Home Medical (CVE:PTQ) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Protech Home Medical and Hamilton Thorne, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|
| Protech Home Medical | 0 | 0 | 5 | 0 | 3.00 |
| Hamilton Thorne | 0 | 0 | 4 | 0 | 3.00 |
Protech Home Medical currently has a consensus target price of C$2.58, indicating a potential upside of 19.05%. Hamilton Thorne has a consensus target price of C$1.87, indicating a potential upside of 10.00%. Given Protech Home Medical's higher possible upside, research analysts plainly believe Protech Home Medical is more favorable than Hamilton Thorne.
Profitability
This table compares Protech Home Medical and Hamilton Thorne's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
|---|
| Protech Home Medical | N/A | N/A | N/A |
| Hamilton Thorne | N/A | N/A | N/A |
Earnings and Valuation
This table compares Protech Home Medical and Hamilton Thorne's top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|
| Protech Home Medical | C$82.22 million | 2.98 | C$-5,417,568.00 | C($0.05) | -45.21 |
| Hamilton Thorne | C$38.36 million | 5.84 | C$922,803.00 | C$0.01 | 242.86 |
Hamilton Thorne has lower revenue, but higher earnings than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.
Summary
Hamilton Thorne beats Protech Home Medical on 4 of the 7 factors compared between the two stocks.
